SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-027352
Filing Date
2018-01-31
Accepted
2018-01-31 16:03:15
Documents
4
Effectiveness Date
2018-01-31

Document Format Files

Seq Description Document Type Size
1 S-8 d532043ds8.htm S-8 69789
2 EX-5.1 d532043dex51.htm EX-5.1 5244
3 EX-23.1 d532043dex231.htm EX-23.1 1314
4 GRAPHIC g532043g64a56.jpg GRAPHIC 3170
  Complete submission text file 0001193125-18-027352.txt   81873
Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-222803 | Film No.: 18562696
SIC: 2834 Pharmaceutical Preparations